Efficacy and Safety of AVP-21D9, an Anthrax Monoclonal Antibody, in Animal Models and Humans

Anthrax is an acute infectious disease caused by the spore-forming bacterium Bacillus anthracis. Timely administration of antibiotics approved for the treatment of anthrax disease may prevent associated morbidity and mortality. However, any delay in initiating antimicrobial therapy may result in inc...

詳細記述

保存先:
書誌詳細
主要な著者: Malkevich, Nina V., Hopkins, Robert J., Bernton, Edward, Meister, Gabriel T., Vela, Eric M., Atiee, George, Johnson, Virginia, Nabors, Gary S., Aimes, Ronald T., Ionin, Boris, Skiadopoulos, Mario H.
フォーマット: Artigo
言語:Inglês
出版事項: American Society for Microbiology 2014
主題:
Experimental Therapeutics
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4068543/
https://ncbi.nlm.nih.gov/pubmed/24733473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02295-13
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料